Location · Cordele, GA
Clinical trials in Cordele, GA
10 recruiting studies have a site in Cordele, and 0 of them accept healthy volunteers.
10 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
AstraZeneca
- Location
- Cordele, GA + 151 other US sites
- Eligibility basics
- Ages 40+
- RecruitingPhase 4
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
Sanofi
- Location
- Cordele, GA + 10 other US sites
- Eligibility basics
- Ages 40–85
- RecruitingPhase 2
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
Biomea Fusion Inc.
- Location
- Cordele, GA + 19 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Sanofi
- Location
- Cordele, GA + 72 other US sites
- Eligibility basics
- Ages 40–80
- RecruitingPhase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
AstraZeneca
- Location
- Cordele, GA + 53 other US sites
- Eligibility basics
- Ages 40–80
- RecruitingPhase 3
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
GlaxoSmithKline
- Location
- Cordele, GA + 50 other US sites
- Eligibility basics
- Ages 40–80
- RecruitingPhase 2/Phase 3
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
CSL Behring
- Location
- Cordele, GA + 147 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
GlaxoSmithKline
- Location
- Cordele, GA + 37 other US sites
- Eligibility basics
- Ages 40–75
- RecruitingPhase 2
A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
Maze Therapeutics
- Location
- Cordele, GA + 58 other US sites
- Eligibility basics
- Ages 18–68
- RecruitingPhase 2
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
Housey Healthcare ULC
- Location
- Cordele, GA + 24 other US sites
- Eligibility basics
- Ages 18+